Citadel Advisors’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2023
Q1
Sell
-200,096
Closed -$177K 6997
2022
Q4
$177K Sell
200,096
-1,348,958
-87% -$1.2M ﹤0.01% 4766
2022
Q3
$2.43M Buy
1,549,054
+884,632
+133% +$1.39M ﹤0.01% 2547
2022
Q2
$1.34M Sell
664,422
-1,029,400
-61% -$2.07M ﹤0.01% 3106
2022
Q1
$3.95M Buy
1,693,822
+691,099
+69% +$1.61M ﹤0.01% 2294
2021
Q4
$4.66M Buy
1,002,723
+774,668
+340% +$3.6M ﹤0.01% 2167
2021
Q3
$1.74M Buy
228,055
+154,832
+211% +$1.18M ﹤0.01% 3171
2021
Q2
$710K Sell
73,223
-503,355
-87% -$4.88M ﹤0.01% 4378
2021
Q1
$4.77M Buy
576,578
+521,598
+949% +$4.31M ﹤0.01% 2159
2020
Q4
$375K Sell
54,980
-298
-0.5% -$2.03K ﹤0.01% 4070
2020
Q3
$616K Sell
55,278
-364,991
-87% -$4.07M ﹤0.01% 3315
2020
Q2
$2.64M Buy
+420,269
New +$2.64M ﹤0.01% 2005
2020
Q1
Hold
0
5475
2019
Q4
Sell
-298,565
Closed -$639K 5288
2019
Q3
$639K Sell
298,565
-62,748
-17% -$134K ﹤0.01% 3277
2019
Q2
$965K Buy
361,313
+318,848
+751% +$852K ﹤0.01% 3009
2019
Q1
$202K Sell
42,465
-218,610
-84% -$1.04M ﹤0.01% 3956
2018
Q4
$627K Buy
261,075
+247,468
+1,819% +$594K ﹤0.01% 3126
2018
Q3
$60K Sell
13,607
-64,075
-82% -$283K ﹤0.01% 3985
2018
Q2
$559K Buy
77,682
+53,703
+224% +$386K ﹤0.01% 3068
2018
Q1
$123K Buy
23,979
+11,393
+91% +$58.4K ﹤0.01% 3601
2017
Q4
$48K Sell
12,586
-20,137
-62% -$76.8K ﹤0.01% 3634
2017
Q3
$56K Buy
+32,723
New +$56K ﹤0.01% 3398
2017
Q2
Sell
-19,476
Closed -$77K 4323
2017
Q1
$77K Buy
+19,476
New +$77K ﹤0.01% 3355
2016
Q4
Sell
-14,100
Closed -$109K 4254
2016
Q3
$109K Buy
+14,100
New +$109K ﹤0.01% 3184
2016
Q1
Sell
-28,792
Closed -$251K 4128
2015
Q4
$251K Buy
28,792
+27,431
+2,016% +$239K ﹤0.01% 2827
2015
Q3
$11K Sell
1,361
-66,830
-98% -$540K ﹤0.01% 3873
2015
Q2
$1.2M Sell
68,191
-7,946
-10% -$140K ﹤0.01% 2033
2015
Q1
$880K Buy
+76,137
New +$880K ﹤0.01% 2278